A clinical trial is being conducted by early-stage medtech firm IDx to secure FDA clearance for its IDx-DR, an automated screening solution designed for diabetic retinopathy. The study will include more than 850 patients with diabetes and will involve capturing images of their eyes to be submitted to the IDx-DR software for algorithm-based detection of diabetic retinopathy symptoms.
Trial evaluates IDx's automated screening solution for diabetic retinopathy
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.